Psoriasis is a chronic, inflammatory, autoimmune skin disease that can affect children, adolescents, and adults. Although adult psoriasis and pediatric psoriasis are similar, effective management of pediatric psoriasis is more challenging owing to limited treatments approved for children. Although topical corticosteroids continue to be the mainstay of pediatric psoriasis treatment, there is an increase in biologics use owing to the more frequent and severe adverse events associated with the long-term use of topical corticosteroids in children. Use of conventional systemics also appears to be on the decline, further underscoring a growing need for treatments with more-acceptable safety profiles.
Treatment Algorithms: Claims Data Analysis provides detailed, quantitative analysis of the treatment journey and brand usage across lines of therapy and overall using real-world, patient-level claims data so that marketers can accurately assess their source of business, benchmark usage against competitors, and quantify areas of opportunity for their marketed or emerging brand.
Markets covered: United States
Key companies: AbbVie, Amgen, Bausch Health, Eli Lilly, Janssen, Novartis
Key drugs: Cosentyx, Elidel, Enbrel, Humira, Stelara, Taclonex, Taltz, Tremfya